0.00Open0.08Pre Close0 Volume152 Open Interest1.50Strike Price0.00Turnover2654.74%IV359.30%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type0.4087Delta0.7389Gamma4.31Leverage Ratio-0.0797Theta0.0000Rho1.76Eff Leverage0.0001Vega
FibroGen Stock Discussion
.36
hope you can perform again 💪💪💪
FibroGen Inc - Study Did Not Meet Primary Endpoint
FibroGen, Inc. (NASDAQ:FGEN) recently announced a milestone in its oncology pipeline. The U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for FG-3165, a novel galectin-9 (Gal9) targeted monoc...
No comment yet